Would prostate cancer detected by screening withprostate‐specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population‐based studies in Sweden

Objective To assess the risk of over‐diagnosing and over‐treating prostate cancer if population‐based screening with serum prostate‐specific antigen (PSA) is instituted.

[1]  E. Varenhorst,et al.  The cost of prostatic cancer in a defined population. , 1989, Scandinavian journal of urology and nephrology.

[2]  J. Hugosson,et al.  Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. , 1995, The Journal of urology.

[3]  P. Humphrey,et al.  Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. , 1996, The Journal of urology.

[4]  J. Oesterling,et al.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.

[5]  P C Prorok,et al.  Prostate Cancer Screening: What We Know and What We Need To Know , 1993, Annals of Internal Medicine.

[6]  J. Hugosson,et al.  Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer. , 1996, The Urologic clinics of North America.

[7]  J. Hugosson,et al.  Long-term survival and mortality in prostate cancer treated with noncurative intent. , 1995, The Journal of urology.

[8]  J. Hugosson,et al.  Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen. , 1998, The Journal of urology.

[9]  B. G. Blijenberg,et al.  The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men. , 1995, Urology.

[10]  S. Fosså,et al.  The burden of prostate cancer from diagnosis until death. , 1995, British journal of urology.

[11]  H. Adami,et al.  Ethics of a prostate cancer screening trial , 1994, The Lancet.

[12]  P. Troncoso,et al.  Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. , 1995, The Journal of urology.

[13]  R. A. Jones,et al.  Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. , 1997, British journal of urology.

[14]  R. Vessella,et al.  Screening for prostatic carcinoma with prostate specific antigen. , 1992, The Journal of urology.

[15]  H. Adami,et al.  The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913. , 1995, The Journal of urology.

[16]  N. Bolton,et al.  Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands , 1983, The Prostate.

[17]  D. Fryback,et al.  Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.

[18]  Curtis Mettlin,et al.  Defining and updating the american cancer society guidelines for the cancer‐related checkup: Prostate and endometrial cancers , 1993, CA: a cancer journal for clinicians.

[19]  J. Oesterling,et al.  In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. , 1996, Urology.

[20]  J. Goméz,et al.  Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen. , 1996, Urology.

[21]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[22]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[23]  P. Knekt,et al.  Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer , 1994, The Lancet.

[24]  Z. Hall.  Cancer , 1906, The Hospital.

[25]  Igor Sartori,et al.  Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate- Specific Antigen-Based Screening: , 1994 .

[26]  W. Catalona,et al.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.

[27]  M. Garnick,et al.  Prostate Cancer: Screening, Diagnosis, and Management , 1993, Annals of Internal Medicine.

[28]  F. Schröder,et al.  The TNM classification of prostate cancer , 1992, The Prostate. Supplement.

[29]  P. Björntorp,et al.  The Pituitary-Gonadal Axis and Health in Elderly Men: A Study of Men Born in 1913 , 1996, Diabetes.